Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter ablation versus amiodarone to prevent future ICD shock episodes after myocardial infarction
2009-011790-32Phase 4Terminated
- Sponsor
- Isala
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone in ventricular tachycardia (VT), ventricular fibrillation (VF), myocardial infarction (MI) and 1 more (2 arms), sponsored by Isala. Primary endpoint: Time to recurrence of ICD shock therapy for VT or VF. Started Mar 2009; status: terminated.
02
Drugs
amiodarone
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)myocardial infarction (MI)ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on 2009-011790-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011790-32.